Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Silvasta Sildenafil citrate 35.12mg equivalent to 25mg sildenafil Tablet Douglas Pharmaceuticals Limited Actavis ehf, Hafnarfjordur, Iceland Actavis Limited, Zejtun, Malta
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Silvasta Sildenafil citrate 70.24mg equivalent to 50mg sildenafil Tablet Douglas Pharmaceuticals Limited Actavis ehf, Hafnarfjordur, Iceland Actavis Limited, Zejtun, Malta
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Silvasta Sildenafil citrate 140.48mg equivalent to 100mg sildenafil Tablet Douglas Pharmaceuticals Limited Actavis ehf, Hafnarfjordur, Iceland Actavis Limited, Zejtun, Malta
|
Dated this 6th day of March 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).